$VCYT
Veracyte Inc Stock $vcyt

$vcyt Overview Financials Valuation SEC Filings Company Website

2017 Q3 Form 10-Q Financial Statement

#000138410117000050 Filed on July 31, 2017

Income Statement

Concept	2017 Q3	2017 Q2	2016 Q2
Revenue	$17.52M	$18.41M	$14.68M
YoY Change	-5.83%	25.42%	23.24%
Cost Of Revenue	$7.169M	$6.960M	$6.301M
YoY Change	12.6%	10.46%	22.61%
Gross Profit	$10.35M	$11.45M	$8.374M
YoY Change	-15.41%	36.68%	23.71%
Gross Profit Margin	59.08%	62.19%	57.06%
Selling, General & Admin	$13.41M	$14.19M	$14.33M
YoY Change	4.32%	-1.03%	14.92%
% of Gross Profit	129.52%	123.94%	171.17%
Research & Development	$3.046M	$3.603M	$4.267M
YoY Change	-23.96%	-15.56%	37.51%
% of Gross Profit	29.43%	31.48%	50.96%
Depreciation & Amortization	$990.0K	$950.0K	$940.0K
YoY Change	10.0%	1.06%	44.62%
% of Gross Profit	9.57%	8.3%	11.23%
Operating Expenses	$16.45M	$17.79M	$18.60M
YoY Change	-2.4%	-4.37%	19.42%
Operating Profit	-$6.368M	-$6.609M	-$10.49M
YoY Change	30.33%	-37.02%	15.65%
Interest Expense	$815.0K	$808.0K	$785.0K
YoY Change	2.0%	2.93%	772.22%
% of Operating Profit
Other Income/Expense, Net	$134.0K	$119.0K	$36.00K
YoY Change	179.17%	230.56%	28.57%
Pretax Income	-$7.050M	-$7.300M	-$11.24M
YoY Change	25.0%	-35.05%	22.98%
Income Tax
% Of Pretax Income
Net Earnings	-$7.050M	-$7.300M	-$11.24M
YoY Change	25.0%	-35.05%	22.98%
Net Earnings / Revenue	-40.24%	-39.66%	-76.59%
Basic Earnings Per Share
Diluted Earnings Per Share	-$207.7K	-$215.5K	-$403.4K
COMMON SHARES
Basic Shares Outstanding	33.89M shares	33.87M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2017 Q3	2017 Q2	2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$41.20M	$46.50M	$39.00M
YoY Change	29.97%	19.23%	-23.53%
Cash & Equivalents	$41.20M	$46.46M	$38.99M
Short-Term Investments
Other Short-Term Assets	$1.600M	$2.000M	$1.500M
YoY Change	6.67%	33.33%	-28.57%
Inventory	$3.760M	$3.317M	$3.502M
Prepaid Expenses
Receivables	$11.64M	$11.03M	$3.387M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$58.21M	$62.86M	$47.40M
YoY Change	35.52%	32.62%	-21.92%
LONG-TERM ASSETS
Property, Plant & Equipment	$10.28M	$10.09M	$10.94M
YoY Change	-1.48%	-7.72%	160.4%
Goodwill	$1.057M	$1.057M	$1.057M
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$178.0K	$134.0K	$172.0K
YoY Change	-12.32%	-22.09%	-78.5%
Total Long-Term Assets	$25.45M	$25.49M	$27.44M
YoY Change	-4.67%	-7.1%	25.85%
TOTAL ASSETS
Total Short-Term Assets	$58.21M	$62.86M	$47.40M
Total Long-Term Assets	$25.45M	$25.49M	$27.44M
Total Assets	$83.66M	$88.35M	$74.83M
YoY Change	20.11%	18.06%	-9.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.161M	$2.349M	$2.705M
YoY Change	2.6%	-13.16%	0.19%
Accrued Expenses	$8.058M	$8.450M	$8.910M
YoY Change	12.09%	-5.16%	23.75%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$11.22M	$10.80M	$11.84M
YoY Change	9.24%	-8.81%	0.36%
LONG-TERM LIABILITIES
Long-Term Debt	$25.00M	$24.97M	$24.67M
YoY Change	0.43%	1.22%	393.42%
Other Long-Term Liabilities	$4.200M	$4.300M	$4.600M
YoY Change	-6.67%	-6.52%	1050.0%
Total Long-Term Liabilities	$25.00M	$24.97M	$24.67M
YoY Change	0.43%	1.22%	356.87%
TOTAL LIABILITIES
Total Short-Term Liabilities	$11.22M	$10.80M	$11.84M
Total Long-Term Liabilities	$25.00M	$24.97M	$24.67M
Total Liabilities	$40.84M	$40.50M	$41.08M
YoY Change	3.02%	-1.4%	136.09%
SHAREHOLDERS EQUITY
Retained Earnings	-$202.6M	-$195.6M	-$170.0M
YoY Change	15.35%	15.03%
Common Stock	$245.5M	$243.4M	$203.8M
YoY Change	19.34%	19.45%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$42.82M	$47.84M	$33.75M
YoY Change
Total Liabilities & Shareholders Equity	$83.66M	$88.35M	$74.83M
YoY Change	20.11%	18.06%	-9.29%

Cashflow Statement

Concept	2017 Q3	2017 Q2	2016 Q2
OPERATING ACTIVITIES
Net Income	-$7.050M	-$7.300M	-$11.24M
YoY Change	25.0%	-35.05%	22.98%
Depreciation, Depletion And Amortization	$990.0K	$950.0K	$940.0K
YoY Change	10.0%	1.06%	44.62%
Cash From Operating Activities	-$5.100M	-$4.910M	-$7.710M
YoY Change	-31.45%	-36.32%	-32.72%
INVESTING ACTIVITIES
Capital Expenditures	-$730.0K	-$110.0K	-$730.0K
YoY Change	329.41%	-84.93%	114.71%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$120.0K
YoY Change		-100.0%	-120.0%
Cash From Investing Activities	-$730.0K	-$110.0K	-$610.0K
YoY Change	329.41%	-81.97%	-35.79%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	440.0K	-20.00K	-140.0K
YoY Change	37.5%	-85.71%	-100.37%
NET CHANGE
Cash From Operating Activities	-5.100M	-4.910M	-7.710M
Cash From Investing Activities	-730.0K	-110.0K	-610.0K
Cash From Financing Activities	440.0K	-20.00K	-140.0K
Net Change In Cash	-5.390M	-5.040M	-8.460M
YoY Change	-26.06%	-40.43%	-133.5%
FREE CASH FLOW
Cash From Operating Activities	-$5.100M	-$4.910M	-$7.710M
Capital Expenditures	-$730.0K	-$110.0K	-$730.0K
Free Cash Flow	-$4.370M	-$4.800M	-$6.980M
YoY Change	-39.89%	-31.23%	-37.23%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	239631000	USD
CY2017Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	243409000	USD
CY2016Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	27000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	118000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	53000	USD
CY2017Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	27000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	53000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	119000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
	dei	Document Period End Date DocumentPeriodEndDate	2017-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001384101
CY2017Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	33893567	shares
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	VERACYTE, INC.
	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2424000	USD
CY2017Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2349000	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	8756000	USD
CY2017Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	11027000	USD
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9110000	USD
CY2017Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8450000	USD
CY2016Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	267000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	534000	USD
CY2017Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	266000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	533000	USD
CY2016Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5368320	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4927251	shares
CY2017Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6547997	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6129854	shares
CY2016Q4	us-gaap	Assets Assets	101034000	USD
CY2017Q2	us-gaap	Assets Assets	88347000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	73627000	USD
CY2016Q2	us-gaap	Cost Of Revenue CostOfRevenue	6301000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	12580000	USD
CY2017Q2	us-gaap	Cost Of Revenue CostOfRevenue	6960000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	13257000	USD
CY2016Q2	us-gaap	Costs And Expenses CostsAndExpenses	25169000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	48470000	USD
CY2017Q2	us-gaap	Costs And Expenses CostsAndExpenses	25015000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	48964000	USD
CY2016Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	4402000	USD
CY2017Q2	us-gaap	Assets Current AssetsCurrent	62860000	USD
CY2016Q4	us-gaap	Capital Lease Obligations CapitalLeaseObligations	599000	USD
CY2017Q2	us-gaap	Capital Lease Obligations CapitalLeaseObligations	456000	USD
CY2016Q2	us-gaap	Capital Leases Income Statement Interest Expense CapitalLeasesIncomeStatementInterestExpense	0	USD
	us-gaap	Capital Leases Income Statement Interest Expense CapitalLeasesIncomeStatementInterestExpense	0	USD
CY2017Q2	us-gaap	Capital Leases Income Statement Interest Expense CapitalLeasesIncomeStatementInterestExpense	12000	USD
	us-gaap	Capital Leases Income Statement Interest Expense CapitalLeasesIncomeStatementInterestExpense	23000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	39084000	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	38993000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	59219000	USD
CY2017Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	46463000	USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	6748609	shares
CY2017Q2	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	7969561	shares
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2017Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2017Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33762278	shares
CY2017Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33891817	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33762278	shares
CY2017Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33891817	shares
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	34000	USD
CY2017Q2	us-gaap	Common Stock Value CommonStockValue	34000	USD
CY2016Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-11243000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-21318000	USD
CY2017Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7298000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-15515000	USD
CY2017Q2	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	4277000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1703000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1846000	USD
CY2016Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.40
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.77
CY2017Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.22
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.46
CY2016Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	6120000	USD
CY2017Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4945000	USD
CY2017Q2	us-gaap	Inventory Net InventoryNet	3317000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	41453000	USD
CY2017Q2	us-gaap	Liabilities Liabilities	40503000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	101034000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	14133000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	13600000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-12000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2016Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6071000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12299000	USD
CY2017Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6192000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12211000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	1057000	USD
CY2017Q2	us-gaap	Goodwill Goodwill	1057000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-805000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	266000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-48000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2271000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-265000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-158000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	13000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	0	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-47000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-25000	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	2000	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
CY2016Q2	us-gaap	Interest Expense InterestExpense	785000	USD
	us-gaap	Interest Expense InterestExpense	1152000	USD
CY2017Q2	us-gaap	Interest Expense InterestExpense	808000	USD
	us-gaap	Interest Expense InterestExpense	1608000	USD
CY2016Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	785000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	1152000	USD
CY2017Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	808000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	1608000	USD
CY2016Q2	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	758000	USD
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	828000	USD
CY2017Q2	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	769000	USD
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	1532000	USD
CY2016Q4	us-gaap	Inventory Net InventoryNet	3475000	USD
CY2017Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	88347000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	11534000	USD
CY2017Q2	us-gaap	Liabilities Current LiabilitiesCurrent	10799000	USD
CY2016Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	24918000	USD
CY2017Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	24971000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-91000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-12756000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	19810000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	528000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-3589000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-288000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-16312000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-12996000	USD
CY2016Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11243000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-21318000	USD
CY2017Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7298000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-15515000	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-10494000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-20245000	USD
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-6609000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-14126000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	19245000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	2144000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	2082000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	2026000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	2102000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	9812000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	1079000	USD
CY2016Q2	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	457000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	1100000	USD
CY2017Q2	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	455000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	912000	USD
CY2016Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2990000	USD
CY2017Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3505000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	134000	USD
CY2017Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	134000	USD
CY2016Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	36000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	79000	USD
CY2017Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	119000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	219000	USD
	us-gaap	Paid In Kind Interest PaidInKindInterest	192000	USD
	us-gaap	Paid In Kind Interest PaidInKindInterest	0	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3587000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	728000	USD
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2017Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2017Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2057000	USD
CY2017Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1933000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	200000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	24452000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	440000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	646000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	463000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11480000	USD
CY2017Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10093000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	68000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	USD
	us-gaap	Recognition Of Deferred Revenue RecognitionOfDeferredRevenue	721000	USD
	us-gaap	Recognition Of Deferred Revenue RecognitionOfDeferredRevenue	0	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	0	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	135000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	5000000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2016Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4267000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7728000	USD
CY2017Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3603000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7633000	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	120000	USD
CY2017Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	120000	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	603000	USD
CY2017Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	603000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-180084000	USD
CY2017Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-195599000	USD
CY2016Q2	us-gaap	Sales Revenue Net SalesRevenueNet	14675000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	28225000	USD
CY2017Q2	us-gaap	Sales Revenue Net SalesRevenueNet	18406000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	34838000	USD
CY2016Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	8263000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	15329000	USD
CY2017Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	7994000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	15330000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	3173000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	3214000	USD
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5251832	shares
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6394917	shares
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	59581000	USD
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	33848645	shares
CY2017Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2400000	USD
CY2017Q2	us-gaap	Stockholders Equity StockholdersEquity	47844000	USD
	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	USD
CY2016Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	27859918	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	27838955	shares
CY2017Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	33873128	shares
	vcyt	Capital Expenditures Incurred But Not Yet Paid Net CapitalExpendituresIncurredButNotYetPaidNet	42000	USD
	vcyt	Capital Expenditures Incurred But Not Yet Paid Net CapitalExpendituresIncurredButNotYetPaidNet	0	USD
CY2016Q2	vcyt	Debt Instrument End Of Term Payment Interest Amount DebtInstrumentEndOfTermPaymentInterestAmount	0	USD
	vcyt	Debt Instrument End Of Term Payment Interest Amount DebtInstrumentEndOfTermPaymentInterestAmount	156000	USD
CY2017Q2	vcyt	Debt Instrument End Of Term Payment Interest Amount DebtInstrumentEndOfTermPaymentInterestAmount	0	USD
	vcyt	Debt Instrument End Of Term Payment Interest Amount DebtInstrumentEndOfTermPaymentInterestAmount	0	USD
	vcyt	Increase Decrease In Accrued Liabilities And Deferred Rent IncreaseDecreaseInAccruedLiabilitiesAndDeferredRent	712000	USD
	vcyt	Increase Decrease In Accrued Liabilities And Deferred Rent IncreaseDecreaseInAccruedLiabilitiesAndDeferredRent	-772000	USD
	vcyt	Interest Expenseand Prepayment Penalty InterestExpenseandPrepaymentPenalty	206000	USD
	vcyt	Interest Expenseand Prepayment Penalty InterestExpenseandPrepaymentPenalty	0	USD
CY2017Q2	vcyt	Number Of Major Financial Institutions With Which Cash And Cash Equivalents Deposited NumberOfMajorFinancialInstitutionsWithWhichCashAndCashEquivalentsDeposited	1
	vcyt	Payment Of End Of Term Obligation PaymentOfEndOfTermObligation	288000	USD
	vcyt	Payment Of End Of Term Obligation PaymentOfEndOfTermObligation	0	USD
CY2016Q2	vcyt	Prepayment Penalty PrepaymentPenalty	0	USD
	vcyt	Prepayment Penalty PrepaymentPenalty	50000	USD
CY2017Q2	vcyt	Prepayment Penalty PrepaymentPenalty	0	USD
	vcyt	Prepayment Penalty PrepaymentPenalty	0	USD
CY2016Q2	vcyt	Revenue Percent RevenuePercent	1
	vcyt	Revenue Percent RevenuePercent	1
CY2017Q2	vcyt	Revenue Percent RevenuePercent	1
	vcyt	Revenue Percent RevenuePercent	1
CY2016Q2	vcyt	Revenue Recognized On Accrual Basis RevenueRecognizedOnAccrualBasis	5326000	USD
	vcyt	Revenue Recognized On Accrual Basis RevenueRecognizedOnAccrualBasis	10650000	USD
CY2017Q2	vcyt	Revenue Recognized On Accrual Basis RevenueRecognizedOnAccrualBasis	795000	USD
	vcyt	Revenue Recognized On Accrual Basis RevenueRecognizedOnAccrualBasis	2089000	USD
CY2016Q2	vcyt	Revenue Recognized On Accrual Basis Percentage RevenueRecognizedOnAccrualBasisPercentage	0.64
	vcyt	Revenue Recognized On Accrual Basis Percentage RevenueRecognizedOnAccrualBasisPercentage	0.62
CY2017Q2	vcyt	Revenue Recognized On Accrual Basis Percentage RevenueRecognizedOnAccrualBasisPercentage	0.96
	vcyt	Revenue Recognized On Accrual Basis Percentage RevenueRecognizedOnAccrualBasisPercentage	0.94
CY2016Q2	vcyt	Revenue Recognized Received In Cash RevenueRecognizedReceivedInCash	9349000	USD
	vcyt	Revenue Recognized Received In Cash RevenueRecognizedReceivedInCash	17575000	USD
CY2017Q2	vcyt	Revenue Recognized Received In Cash RevenueRecognizedReceivedInCash	17611000	USD
	vcyt	Revenue Recognized Received In Cash RevenueRecognizedReceivedInCash	32749000	USD
CY2016Q2	vcyt	Revenue Recognized Received In Cash Percentage RevenueRecognizedReceivedInCashPercentage	0.36
	vcyt	Revenue Recognized Received In Cash Percentage RevenueRecognizedReceivedInCashPercentage	0.38
CY2017Q2	vcyt	Revenue Recognized Received In Cash Percentage RevenueRecognizedReceivedInCashPercentage	0.04
	vcyt	Revenue Recognized Received In Cash Percentage RevenueRecognizedReceivedInCashPercentage	0.06
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of unaudited interim financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Significant items subject to such estimates include: revenue recognition; contractual allowances; the useful lives of property and equipment; the recoverability of long-lived assets; the estimation of the fair value of intangible assets; stock options; income tax uncertainties, including a valuation allowance for deferred tax assets; and contingencies. The Company bases these estimates on historical and anticipated results, trends and various other assumptions that the Company believes are reasonable under the circumstances, including assumptions as to future events. These estimates form the basis for making judgments about the carrying values of assets and liabilities and recorded revenue and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and assumptions.</font></div></div>

Files In Submission

Name	View Source	Status
vcyt-20170630_lab.xml	Edgar Link	unprocessable
0001384101-17-000050-index-headers.html	Edgar Link	pending
0001384101-17-000050-index.html	Edgar Link	pending
0001384101-17-000050.txt	Edgar Link	pending
0001384101-17-000050-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
vcyt-06302017xex101.htm	Edgar Link	pending
vcyt-06302017xex311.htm	Edgar Link	pending
vcyt-06302017xex312.htm	Edgar Link	pending
vcyt-06302017xex321.htm	Edgar Link	pending
vcyt-06302017xex322.htm	Edgar Link	pending
vcyt-06302017xq210q.htm	Edgar Link	pending
vcyt-20170630.xml	Edgar Link	completed
vcyt-20170630.xsd	Edgar Link	pending
vcyt-20170630_cal.xml	Edgar Link	unprocessable
vcyt-20170630_def.xml	Edgar Link	unprocessable
vcyt-20170630_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VCYT
Veracyte Inc Stock $vcyt

2017 Q3 Form 10-Q Financial Statement

#000138410117000050 Filed on July 31, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VCYT Veracyte Inc Stock $vcyt

2017 Q3 Form 10-Q Financial Statement

#000138410117000050 Filed on July 31, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VCYT
Veracyte Inc Stock $vcyt